drugset / Trial / NCT02959411
Tolvaptan for Advanced or Refractory Heart Failure
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will clarify the clinical usefulness of Tolvaptan therapy in patients with complicated acute decompensated heart failure and hyponatremia (low blood sodium).
Timeline
- Start
- 2016-10
- Primary completion
- 2020-06-30
- Completion
- 2020-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tolvaptan | Small molecule | 15 mg | — |
| Subject | Tolvaptan | Small molecule | 60 mg | — |